Effect of Weight on Hip Excursion During Gait

Effect of Weight on Hip Excursion During Gait in Children With Diplegia

Background: Children with diplegia had considerably larger hip and knee excursion during gait cycle than did normal developing children.

Objective: To investigate the effect of using weight around the ankle on hip excursion in children with diplegia.

Study Overview

• Status: Completed
• Conditions: Gait, Spastic
• Intervention / Treatment: Other: gait training exercises

Detailed Description

Fifty children with spastic diplegic cerebral palsy were assigned into two groups at random (A, B). Both groups had received the same prescribed exercise program with classical gait training for group A and gait training while using weight around ankle for group B. Treatment was conducted for one hour three sessions per week for successive 3 months. Two-dimensional (2D) gait analysis was used to evaluate hip excursion throughout the gait cycle before and after three months of therapy.

• Study Type: Interventional
• Enrollment (Actual): 50
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Egypt
  • Giza, Egypt
    • Nahla

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 7 years to 10 years (Child)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• able to follow simple basic commands,
• identified with gait abnormalities described as level II on Gross Motor Function Classification System (GMFCS).
• diagnosed as spastic diplegia.

Exclusion Criteria:

• severe visual or auditory problems,
• lower limb surgical orthopaedic surgery or
• BOTOX injection in the six months preceding the start of the study,
• and uncontrolled seizures.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: group A; classical gait training	Other: gait training exercises; walking exercises in different directions; Other Names: gait rehabilitation
Experimental: group B; gait training while using weight around ankle	Other: gait training exercises; walking exercises in different directions; Other Names: gait rehabilitation

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
hip excursion	hip excursion during gait cycle	3 months

Collaborators and Investigators

• Sponsor: Cairo University
• Investigators: Principal Investigator: Nahla mohamed, phd, Cairo University

Publications and helpful links

General Publications

• Rodda J, Graham HK. Classification of gait patterns in spastic hemiplegia and spastic diplegia: a basis for a management algorithm. Eur J Neurol. 2001 Nov;8 Suppl 5:98-108. doi: 10.1046/j.1468-1331.2001.00042.x.

Study record dates

Study Major Dates

• Study Start (Actual): August 3, 2022
• Primary Completion (Actual): October 3, 2022
• Study Completion (Actual): October 7, 2022

Study Registration Dates

• First Submitted: October 10, 2022
• First Submitted That Met QC Criteria: October 11, 2022
• First Posted (Actual): October 13, 2022

Study Record Updates

• Last Update Posted (Actual): October 13, 2022
• Last Update Submitted That Met QC Criteria: October 11, 2022
• Last Verified: October 1, 2022

More Information

Terms related to this study

• Keywords: gait; weight; diplegia; Ankle;; hip excursion
• Additional Relevant MeSH Terms: Nervous System Diseases; Neurologic Manifestations; Gait Disorders, Neurologic
• Other Study ID Numbers: weight during gait

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: Yes
• IPD Plan Description: available when contact the corresponding author including protocol
• IPD Sharing Time Frame: after published online
• IPD Sharing Access Criteria: authors
• IPD Sharing Supporting Information Type: Study Protocol

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No